T

Tecon Biology Co Ltd
SZSE:002100

Watchlist Manager
Tecon Biology Co Ltd
SZSE:002100
Watchlist
Price: 6.54 CNY -3.82% Market Closed
Market Cap: 8.9B CNY
Have any thoughts about
Tecon Biology Co Ltd?
Write Note

Tecon Biology Co Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Tecon Biology Co Ltd
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
T
Tecon Biology Co Ltd
SZSE:002100
Income from Continuing Operations
-ÂĄ373.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Tongwei Co Ltd
SSE:600438
Income from Continuing Operations
-ÂĄ2.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Heilongjiang Agriculture Co Ltd
SSE:600598
Income from Continuing Operations
ÂĄ1.1B
CAGR 3-Years
20%
CAGR 5-Years
5%
CAGR 10-Years
6%
B
Beijing Dabeinong Technology Group Co Ltd
SZSE:002385
Income from Continuing Operations
-ÂĄ1.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
New Hope Liuhe Co Ltd
SZSE:000876
Income from Continuing Operations
ÂĄ1.1B
CAGR 3-Years
N/A
CAGR 5-Years
-21%
CAGR 10-Years
-9%
Jiangxi Zhengbang Technology Co Ltd
SZSE:002157
Income from Continuing Operations
ÂĄ9.7B
CAGR 3-Years
67%
CAGR 5-Years
124%
CAGR 10-Years
N/A
No Stocks Found

Tecon Biology Co Ltd
Glance View

Market Cap
8.9B CNY
Industry
Food Products

Tecon Biology Co., Ltd. engages in the production and sale of animal vaccines, feed, and vegetable protein feed. The company is headquartered in Urumqi, Xinjiang and currently employs 5,669 full-time employees. The company went IPO on 2006-12-26. The firm's main businesses and products include premium incomes, slaughter processing and distribution of meat products, pig farming, production and distribution of feeds and veterinary drugs, and agricultural products processing. The firm mainly operates its businesses within domestic markets, with Xinjiang Province as its main market.

Intrinsic Value
9.13 CNY
Undervaluation 28%
Intrinsic Value
Price
T

See Also

What is Tecon Biology Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
-373.1m CNY

Based on the financial report for Sep 30, 2024, Tecon Biology Co Ltd's Income from Continuing Operations amounts to -373.1m CNY.

What is Tecon Biology Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 1Y
34%

Over the last year, the Income from Continuing Operations growth was 34%.

Back to Top